The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.EBI
National Human Genome Research Institute
Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1a inhibitors.EBI
National Human Genome Research Institute
Discovery, synthesis, and biological evaluation of novel SMN protein modulators.EBI
National Human Genome Research Institute
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.EBI
National Human Genome Research Institute
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).EBI
National Human Genome Research Institute
Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.EBI
National Human Genome Research Institute
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.EBI
National Human Genome Research Institute
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.EBI
National Human Genome Research Institute
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).EBI
National Human Genome Research Institute
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.EBI
National Human Genome Research Institute
Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550).EBI
National Human Genome Research Institute
Non-iminosugar glucocerebrosidase small molecule chaperones.EBI
National Human Genome Research Institute
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death.EBI
National Human Genome Research Institute
Characterization of chemical libraries for luciferase inhibitory activity.EBI
National Human Genome Research Institute
Purinones as ubiquitin-specific protease 1 inhibitorsBDB
Forma Therapeutics